Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

323 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Use of a High-Protein Enteral Nutrition Formula to Increase Protein Delivery to Critically Ill Patients: A Randomized, Blinded, Parallel-Group, Feasibility Trial.
Chapple LS, Summers MJ, Bellomo R, Chapman MJ, Davies AR, Ferrie S, Finnis ME, Hurford S, Lange K, Little L, O'Connor SN, Peake SL, Ridley EJ, Young PJ, Williams PJ, Deane AM; TARGET Investigator Collaborative and the ANZICS Clinical Trials Group. Chapple LS, et al. Among authors: little l. JPEN J Parenter Enteral Nutr. 2021 May;45(4):699-709. doi: 10.1002/jpen.2059. Epub 2020 Dec 30. JPEN J Parenter Enteral Nutr. 2021. PMID: 33296079 Clinical Trial.
Energy-Dense versus Routine Enteral Nutrition in the Critically Ill.
TARGET Investigators, for the ANZICS Clinical Trials Group; Chapman M, Peake SL, Bellomo R, Davies A, Deane A, Horowitz M, Hurford S, Lange K, Little L, Mackle D, O’Connor S, Presneill J, Ridley E, Williams P, Young P. TARGET Investigators, for the ANZICS Clinical Trials Group, et al. Among authors: little l. N Engl J Med. 2018 Nov 8;379(19):1823-1834. doi: 10.1056/NEJMoa1811687. Epub 2018 Oct 22. N Engl J Med. 2018. PMID: 30346225 Clinical Trial.
Outcomes Six Months after Delivering 100% or 70% of Enteral Calorie Requirements during Critical Illness (TARGET). A Randomized Controlled Trial.
Deane AM, Little L, Bellomo R, Chapman MJ, Davies AR, Ferrie S, Horowitz M, Hurford S, Lange K, Litton E, Mackle D, O'Connor S, Parker J, Peake SL, Presneill JJ, Ridley EJ, Singh V, van Haren F, Williams P, Young P, Iwashyna TJ. Deane AM, et al. Among authors: little l. Am J Respir Crit Care Med. 2020 Apr 1;201(7):814-822. doi: 10.1164/rccm.201909-1810OC. Am J Respir Crit Care Med. 2020. PMID: 31904995 Clinical Trial.
Venous thromboembolic events in critically ill traumatic brain injury patients.
Skrifvars MB, Bailey M, Presneill J, French C, Nichol A, Little L, Duranteau J, Huet O, Haddad S, Arabi Y, McArthur C, Cooper DJ, Bellomo R; EPO-TBI investigators and the ANZICS Clinical Trials Group. Skrifvars MB, et al. Among authors: little l. Intensive Care Med. 2017 Mar;43(3):419-428. doi: 10.1007/s00134-016-4655-2. Epub 2016 Dec 27. Intensive Care Med. 2017. PMID: 28028552 Clinical Trial.
Statistical analysis plan for the Erythropoietin in Traumatic Brain Injury trial: a randomised controlled trial of erythropoietin versus placebo in moderate and severe traumatic brain injury.
Presneill J, Little L, Nichol A, French C, Cooper DJ, Haddad S, Duranteau J, Huet O, Skrifvars M, Arabi Y, Bellomo R; EPO-TBI Investigators; ANZICS Clinical Trials Group. Presneill J, et al. Among authors: little l. Trials. 2014 Dec 20;15:501. doi: 10.1186/1745-6215-15-501. Trials. 2014. PMID: 25528574 Free PMC article. Clinical Trial.
Erythropoietin Does Not Alter Serum Profiles of Neuronal and Axonal Biomarkers After Traumatic Brain Injury: Findings From the Australian EPO-TBI Clinical Trial.
Hellewell SC, Mondello S, Conquest A, Shaw G, Madorsky I, Deng JV, Little L, Kobeissy F, Bye N, Bellomo R, Cooper DJ, Vallance S, Board J, Morganti-Kossmann MC. Hellewell SC, et al. Among authors: little l. Crit Care Med. 2018 Apr;46(4):554-561. doi: 10.1097/CCM.0000000000002938. Crit Care Med. 2018. PMID: 29278529 Clinical Trial.
323 results